Shadman, M., Munir, T., Robak, T., Brown, J. R., Kahl, B. S., Ghia, P., Giannopoulos, K., Simkovic, M., Österborg, A., Laurenti, L., Walker, P. A., Opat, S. S., Ciepluch, H., Greil, R., Hanna, M., Tani, M., Trneny, M., Brander, D., Flinn, I. W., Grosicki, S., Verner, E., Tedeschi, A., Guibert, S. D., Tumyan, G., Laribi, K., García-Marco, J. A., Li, J., Tian, T., Liu, Y., Korolkiewicz, R., Szeto, A., Tam, C. S., Jurczak, W. (2025). Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-02265